-
1.
公开(公告)号:US20240336976A1
公开(公告)日:2024-10-10
申请号:US18627942
申请日:2024-04-05
Inventor: Nehad Alajez
IPC: C12Q1/6886
CPC classification number: C12Q1/6886 , C12Q2600/106 , C12Q2600/118 , C12Q2600/158
Abstract: Gene signatures predictive of pathological complete response and residual disease in triple negative breast cancer patients have been identified. These discoveries have clinical implications in patient stratification and precision medicine.